| Organism name | Morus alba |
|---|---|
| Genus | Morus |
| Family | Moraceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Morus alba |
|---|---|
| Linked NCBI taxonomy ID | 3498 |
| Linked level | species |
| Family in NCBI taxonomy | Moraceae |
|---|---|
| ID | 3487 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00002378
|
Cyanin
/ Cyanidin 3,5-diglucoside |
No. 1 | No. 15 |
|
||||
|
C00006698
|
Myrtillin
/ Delphinidin 3-O-beta-D-glucopyranoside |
CHEMBL518846
|
No. 2 | No. 15 |
|
|||
|
C00005373
|
Hirsutrin
/ Isoquercetin / Isoquercetrin / (-)-Isoquercetrin / Quercetin 3-glucoside / Quercetin 3-O-beta-D-glucoside / Quercetin-3-O-beta-D-glucopyranoside / Quercetin 3-O-beta-D-glucopyranoside / (-)-Quercetin-3-O-beta-D-glucopyranoside |
CHEMBL33027
CHEMBL309323 CHEMBL250450 CHEMBL251254 CHEMBL457304 CHEMBL1098724 CHEMBL2337335 CHEMBL2337336 |
38 / 43 / 34 | No. 2 | No. 15 |
|
||
|
C00004624
|
Morin
/ 3,5,7,2',4'-Pentahydroxyflavonol / 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one |
CHEMBL28626
|
C008548
|
59 / 40 / 67 | 9 / 8 | No. 3 | No. 15 |
|
|
C00013411
|
Moralbanone
/ 2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-8-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]-4H-1-benzopyran-4-one |
No. 14 | No. 15 |
|
||||
|
C00004061
|
Cyclomulberrin
|
No. 14 | No. 15 |
|
||||
|
C00004028
|
Mulberrin
/ Kuwanon C / Norartocarpin / 2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-3,8-bis(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
CHEMBL518543
|
3 / 0 / 3 | No. 14 | No. 15 |
|
||
|
C00004056
|
Kuwanon B
|
No. 18 | No. 15 |
|
||||
|
C00004057
|
Kuwanon A
|
CHEMBL1770312
|
1 / 0 / 0 | No. 18 | No. 15 |
|
||
|
C00001070
|
Morusin
/ Mulberrochromene / 2-(2,4-Dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL464006
|
C057451
|
16 / 17 / 10 | No. 18 | No. 15 |
|
|
|
C00004059
|
Morusinol
/ Oxydihydromorusin / 2-(2,4-Dihydroxyphenyl)-5-hydroxy-3-(3-hydroxy-3-methylbutyl)-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL1719948
|
10 / 5 / 2 | No. 18 | No. 15 |
|
||
|
C00004029
|
Cyclomorusin
/ Cyclomulberrochromene / 6,11-Dihydroxy-3,3-dimethyl-8-(2-methyl-1-propenyl)-3H,7H,8H-bis[1]benzopyrano[4,3-b:6',5'-e]pyran-7-one |
CHEMBL1770313
|
1 / 0 / 0 | No. 18 | No. 15 |
|
||
|
C00008328
|
Kuwanon E
|
CHEMBL1096939
|
No. 19 | No. 14 |
|
|||
|
C00008382
|
Sanggenon N
|
No. 39 |
|
|||||
|
C00008379
|
Kuwanon F
|
No. 39 |
|
|||||
|
C00008428
|
Kuwanol C
|
No. 39 |
|
|||||
|
C00008381
|
Sanggenon I
|
No. 39 |
|
|||||
|
C00001063
|
Albanin F
/ Kuwanone G |
CHEMBL444942
|
C095194
|
0 / 2 | No. 81 | No. 20 |
|
|
|
C00008095
|
Kuwanon V
|
No. 81 | No. 20 |
|
||||
|
C00008098
|
Kuwanon Y
|
No. 81 | No. 20 |
|
||||
|
C00008101
|
Mulberrofuran E
|
No. 81 | No. 20 |
|
||||
|
C00008104
|
Mulberrofuran T
|
No. 81 | No. 20 |
|
||||
|
C00002405
|
Mulberrofuran C
|
CHEMBL378806
CHEMBL505416 |
2 / 0 / 0 | No. 81 | No. 20 |
|
||
|
C00008384
|
Kuwanon L
|
CHEMBL377937
|
2 / 0 / 0 | No. 81 | No. 20 |
|
||
|
C00001064
|
Kuwanone H
|
CHEMBL506234
|
C095195
|
No. 81 | No. 20 |
|
||
|
C00008086
|
Chalcomoracin
|
CHEMBL508825
CHEMBL1808155 |
No. 81 | No. 20 |
|
|||
|
C00008090
|
Kuwanon K
|
No. 81 | No. 20 |
|
||||
|
C00008088
|
Kuwanon I
|
No. 81 | No. 20 |
|
||||
|
C00008077
|
Albafuran C
|
No. 81 | No. 20 |
|
||||
|
C00008089
|
Kuwanon J
|
No. 81 | No. 20 |
|
||||
|
C00008081
|
Artonin I
|
No. 81 | No. 20 |
|
||||
|
C00008087
|
Kuwanol E
|
No. 81 | No. 20 |
|
||||
|
C00006940
|
2,4,2',4'-Tetrahydroxychalcone
|
CHEMBL394855
|
1 / 2 / 2 | No. 92 | No. 13 |
|
||
|
C00050328
|
Alboctalol
|
No. 108 | No. 30 |
|
||||
|
C00008329
|
Sanggenon F
|
No. 127 | No. 14 |
|
||||
|
C00008330
|
Sanggenon H
|
No. 127 | No. 14 |
|
||||
|
C00007091
|
Morachalcone A
|
CHEMBL465880
|
1 / 2 / 2 | No. 133 | No. 13 |
|
||
|
C00007137
|
Kuwanol D
|
No. 190 | No. 13 |
|
||||
|
C00002403
|
Moracin A
|
No. 210 | No. 15 |
|
||||
|
C00015199
|
Dihydrooxyresveratrol
/ 2,3',4,5'-Tetrahydroxystilbene |
CHEMBL221291
|
1 / 4 / 2 | No. 242 | No. 26 |
|
||
|
C00002893
|
Oxyresveratrol
/ 2,3,4,5'-Tetrahydroxystilbene |
CHEMBL43065
|
20 / 32 / 49 | No. 295 | No. 13 |
|
||
|
C00002404
|
Mulberrofuran A
|
No. 319 | No. 15 |
|
||||
|
C00002391
|
Albafuran A
|
CHEMBL564896
|
1 / 0 / 0 | No. 319 | No. 15 |
|
||
|
C00004020
|
Kuwanon S
/ Kuwanone S / 2-[3-(3,7-Dimethyl-2,6-octadienyl)-4-hydroxyphenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one / 2-[3-[(2E)-3,7-Dimethyl-2,6-octadienyl]-4-hydroxyphenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one |
No. 319 | No. 15 |
|
||||
|
C00036868
|
Calystegine C1
/ (+)-Calystegine C1 |
CHEMBL1972699
|
No. 643 | No. 1 |
|
|||
|
C00002038
|
Fagomine
|
CHEMBL303545
CHEMBL108084 CHEMBL456583 CHEMBL505237 CHEMBL1818435 CHEMBL1818436 CHEMBL1818437 CHEMBL1818438 CHEMBL1818439 |
C105643
|
5 / 9 / 7 | No. 786 | No. 1 |
|
|
|
C00002900
|
4'-Prenyloxyresveratrol
|
No. 1111 | No. 13 |
|
||||
|
C00002704
|
Paeonol
|
CHEMBL1079227
|
C013638
|
4 / 2 / 3 | No. 1494 |
|
||
|
C00003003
|
Maclurin
|
CHEMBL506731
|
No. 1837 |
|
||||
|
C00002392
|
Albanol A
/ Mulberrofuran G |
CHEMBL445265
CHEMBL454705 |
C047825
|
1 / 2 / 2 | 0 / 1 | No. 2657 |
|
|
|
C00008380
|
Kuwanon D
|
No. 3283 |
|
|||||
|
C00002422
|
5,7-Dihydroxychromone
/ 5,7-Dihydroxy-4-chromone |
C080094
|
No. 3998 | No. 15 |
|
|||
|
C00008078
|
Albanol B
|
No. 6601 |
|
|||||
|
C00008099
|
Kuwanon Z
|
No. 7833 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P56817 | Beta-secretase 1 | A1A | C00001070 C00004028 C00004029 C00004057 C00004059 C00004624 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001070 C00002893 C00004028 C00005373 | 0 / 3 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001070 C00002893 C00004059 | 1 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001070 C00004624 C00005373 | 0 / 0 |
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00002392 C00006940 C00007091 | 2 / 2 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001070 C00002893 C00004028 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00002893 C00005373 C00015199 | 4 / 2 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001070 C00004059 C00004624 | 0 / 0 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001070 C00002893 C00004059 | 1 / 1 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00002391 C00002405 C00008384 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00001070 C00002893 C00004059 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002038 C00004624 C00005373 | 1 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00004624 C00005373 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00004624 C00005373 | 4 / 3 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00004624 C00005373 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00004624 C00005373 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00004624 C00005373 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00002038 C00005373 | 6 / 4 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002704 C00004624 | 0 / 1 |
| Q99700 | Ataxin-2 | Unclassified protein | C00001070 C00004059 | 1 / 1 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002704 C00004624 | 2 / 2 |
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004624 C00005373 | 2 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00004624 C00005373 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00004624 C00005373 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002704 C00005373 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00004624 C00005373 | 0 / 0 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00004624 C00005373 | 0 / 1 |
| P37840 | Alpha-synuclein | Unclassified protein | C00001070 C00002893 | 4 / 2 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00004624 C00005373 | 1 / 1 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00004624 C00005373 | 1 / 1 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001070 C00004059 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00004059 C00005373 | 0 / 0 |
| P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00002405 C00008384 | 0 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001070 C00004059 | 2 / 0 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00004624 C00005373 | 1 / 4 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002704 C00004624 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002893 C00004624 | 7 / 37 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00004624 C00005373 | 1 / 0 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00004624 | 0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | C00004624 | 1 / 2 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00004624 | 0 / 0 |
| P07237 | Protein disulfide-isomerase | Enzyme | C00005373 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00005373 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00004624 | 0 / 1 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002893 | 2 / 2 |
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00005373 | 1 / 1 |
| P08183 | Multidrug resistance protein 1 | drug | C00004624 | 1 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00004624 | 0 / 0 |
| P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002038 | 1 / 2 |
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00002893 | 0 / 0 |
| P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002893 | 4 / 2 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00005373 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00004624 | 0 / 1 |
| P15121 | Aldose reductase | Enzyme | C00005373 | 0 / 0 |
| Q14790 | Caspase-8 | C14 | C00004624 | 2 / 1 |
| P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00004624 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00002893 | 0 / 1 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001070 | 7 / 3 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00005373 | 0 / 0 |
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00005373 | 0 / 0 |
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00005373 | 3 / 1 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00004624 | 1 / 2 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00004624 | 0 / 0 |
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00004624 | 1 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00004624 | 0 / 0 |
| Q96S37 | Solute carrier family 22 member 12 | Transporter | C00004624 | 1 / 1 |
| P02545 | Prelamin-A/C | Unclassified protein | C00005373 | 11 / 10 |
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00002893 | 4 / 4 |
| P06280 | Alpha-galactosidase A | Enzyme | C00005373 | 1 / 1 |
| P45452 | Collagenase 3 | M10A | C00002893 | 1 / 1 |
| P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001070 | 2 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00004624 | 0 / 0 |
| Q9HCG7 | Non-lysosomal glucosylceramidase | Enzyme | C00002038 | 1 / 0 |
| P10696 | Alkaline phosphatase, placental-like | Enzyme | C00005373 | 0 / 1 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00002893 | 2 / 2 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002893 | 0 / 0 |
| P08253 | 72 kDa type IV collagenase | M10A | C00002893 | 1 / 3 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00004624 | 3 / 3 |
| P39900 | Macrophage metalloelastase | M10A | C00002893 | 0 / 0 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00004624 | 1 / 1 |
| P29466 | Caspase-1 | C14 | C00004624 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002893 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00005373 | 0 / 0 |
| P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | C00004624 | 0 / 0 |
| Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00004624 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00004624 | 0 / 0 |
| P55210 | Caspase-7 | C14 | C00004624 | 0 / 0 |
| Q14697 | Neutral alpha-glucosidase AB | Enzyme | C00002038 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00004624 | 0 / 0 |
| Q15046 | Lysine--tRNA ligase | Enzyme | C00004624 | 2 / 1 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00004624 | 2 / 2 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00004624 | 0 / 0 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00001070 | 0 / 0 |
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00004624 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001070 | 0 / 0 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00005373 | 1 / 0 |
| Q04760 | Lactoylglutathione lyase | Enzyme | C00004624 | 0 / 0 |
| P08254 | Stromelysin-1 | M10A | C00002893 | 1 / 0 |
| P34949 | Mannose-6-phosphate isomerase | Enzyme | C00005373 | 1 / 1 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00004624 | 2 / 0 |
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00004624 | 0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00004624 | 0 / 0 |
| P40225 | Thrombopoietin | Unclassified protein | C00004624 | 1 / 1 |
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00004624 | 1 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00004624 | 1 / 1 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00005373 | 4 / 1 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00004059 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00004624 | 2 / 5 |
| Q9NPH5 | NADPH oxidase 4 | Enzyme | C00005373 | 0 / 0 |
| Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00004624 | 0 / 0 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00005373 | 0 / 0 |
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00004624 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004624
|
| 351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00004624
|
| 3458 | IFNG, IFG, IFI | interferon, gamma |
C00004624
|
| 6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00004624
|
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00004624
|
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00004624
|
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00004624
|
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00004624
|
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00004624
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #613546 | Aromatase deficiency |
P11511
|
| #139300 | Aromatase excess syndrome; aexs |
P11511
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #614490 | Blood group, junior system; jr |
Q9UNQ0
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #114480 | Breast cancer |
P38398
|
| #604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #607271 | Caspase 8 deficiency |
Q14790
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
| #114500 | Colorectal cancer; crc |
P18054
P84022 |
| #602579 | Congenital disorder of glycosylation, type ib; cdg1b |
P34949
|
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
P18054 |
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #230000 | Fucosidosis |
P04066
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
| #231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
| #137760 | Glaucoma, primary open angle; poag |
Q16678
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #146300 | Hypophosphatasia, adult |
P05186
|
| #241510 | Hypophosphatasia, childhood |
P05186
|
| #241500 | Hypophosphatasia, infantile |
P05186
|
| #220150 | Hypouricemia, renal, 1; rhuc1 |
Q96S37
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #601626 | Leukemia, acute myeloid; aml |
P36888
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P04637
Q14790 |
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #167000 | Ovarian cancer |
P38398
|
| #614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #604229 | Peters anomaly |
Q16678
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #614409 | Spastic paraplegia 46, autosomal recessive; spg46 |
Q9HCG7
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #187950 | Thrombocythemia 1; thcyt1 |
P40225
|
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
| #278300 | Xanthinuria, type i |
P47989
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q15046 (related) |
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00028 | Choriocarcinoma |
P03956
(related)
P04637 (related) P08253 (related) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00141 | Fucosidosis |
P04066
(related)
|
| H00422 | Glycoproteinoses |
P04066
(related)
|
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
| H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P04637
(related)
|
| H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00022 | Bladder cancer |
P04637
(related)
|
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
| H00026 | Endometrial Cancer |
P04637
(related)
Q92731 (marker) |
| H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00042 | Glioma |
P04637
(related)
P04637 (marker) |
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00213 | Hypophosphatasia |
P05186
(related)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00023 | Testicular cancer |
P10696
(marker)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P11511
(related)
|
| H00794 | Aromatase excess syndrome |
P11511
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00118 | Congenital disorders of glycosylation (CDG) type I |
P34949
(related)
|
| H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00108 | Autoimmune lymphoproliferative syndromes (ALPS) |
Q14790
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00612 | Primary open angle glaucoma |
Q16678
(related)
|
| H01075 | Peters anomaly |
Q16678
(related)
|
| H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
| H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
| H00208 | Hyperbilirubinemia |
Q92887
(related)
|
| H00948 | Renal hypouricemia (RHUC) |
Q96S37
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D009374 | Neoplasms, Experimental |
C00004624
C00002392 |
| D008114 | Liver Neoplasms, Experimental |
C00004624
|
| D007511 | Ischemia |
C00004624
|
| D007674 | Kidney Diseases |
C00004624
|
| D008106 | Liver Cirrhosis, Experimental |
C00004624
|
| D056486 | Drug-Induced Liver Injury |
C00004624
|
| D006528 | Carcinoma, Hepatocellular |
C00004624
|
| D015431 | Weight Loss |
C00004624
|
| D003731 | Dental Caries |
C00001063
|
| D010510 | Periodontal Diseases |
C00001063
|